Association of Research on the Biology of Liver Tumors Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT01216345
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

cetuximab (erbitux) (1 trial)

gemcitabine (gemzar) (1 trial)

oxaliplatin (eloxatin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Biliary Tract Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3